https://www.selleckchem.com/products/PD-98059.html
Adequate anti-tuberculosis (T treatment is an important factor that can affect the patient's outcome. Higher mortality is found in patients who do not receive optimal treatment that includes isoniazid and rifampicin. The objective of this study is to evaluate the association of use of alternative TB treatment regimens (without rifampicin and isoniazid) and mortality among patients requiring intensive care. Retrospective cohort study, from January 2010 to December 2018. Patients aged 18years with a TB diagnosis, admitted to the IC
Like
Comment
Share
